Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up - PubMed (original) (raw)
Review
Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up
Marion J Franz et al. J Am Diet Assoc. 2007 Oct.
Abstract
Objective: To assist health professionals who counsel patients with overweight and obesity, a systematic review was undertaken to determine types of weight-loss interventions that contribute to successful outcomes and to define expected weight-loss outcomes from such interventions.
Design: A search was conducted for weight-loss-focused randomized clinical trials with >or=1-year follow-up. Eighty studies were identified and are included in the evidence table.
Outcomes measures: The primary outcomes were a measure of weight loss at 6, 12, 24, 36, and 48 months. Eight types of weight-loss interventions-diet alone, diet and exercise, exercise alone, meal replacements, very-low-energy diets, weight-loss medications (orlistat and sibutramine), and advice alone-were identified. By using simple pooling across studies, subjects mean amount of weight loss at each time point for each intervention was determined.
Statistical analyses performed: Efficacy outcomes were calculated by meta-analysis and provide support for the pooled data. Hedges' gu was combined across studies to obtain an average effect size (and confidence level).
Results: A mean weight loss of 5 to 8.5 kg (5% to 9%) was observed during the first 6 months from interventions involving a reduced-energy diet and/or weight-loss medications with weight plateaus at approximately 6 months. In studies extending to 48 months, a mean 3 to 6 kg (3% to 6%) of weight loss was maintained with none of the groups experiencing weight regain to baseline. In contrast, advice-only and exercise-alone groups experienced minimal weight loss at any time point.
Conclusions: Weight-loss interventions utilizing a reduced-energy diet and exercise are associated with moderate weight loss at 6 months. Although there is some regain of weight, weight loss can be maintained. The addition of weight-loss medications somewhat enhances weight-loss maintenance.
Comment in
- Review: dietary interventions, with or without exercise, promote weight loss more than advice alone.
Vorderstrasse AA. Vorderstrasse AA. Evid Based Nurs. 2008 Apr;11(2):44. doi: 10.1136/ebn.11.2.44. Evid Based Nurs. 2008. PMID: 18364414 No abstract available. - Review: diet interventions, with or without exercise, promote weight loss more than advice alone.
Sharma AM. Sharma AM. Evid Based Med. 2008 Apr;13(2):41. doi: 10.1136/ebm.13.2.41. Evid Based Med. 2008. PMID: 18375694 No abstract available.
Similar articles
- Long-term pharmacotherapy for obesity and overweight.
Padwal R, Li SK, Lau DC. Padwal R, et al. Cochrane Database Syst Rev. 2003;(4):CD004094. doi: 10.1002/14651858.CD004094. Cochrane Database Syst Rev. 2003. PMID: 14584004 Updated. Review. - Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance.
Gursoy A, Erdogan MF, Cin MO, Cesur M, Baskal N. Gursoy A, et al. Eat Weight Disord. 2006 Dec;11(4):e127-32. doi: 10.1007/BF03327578. Eat Weight Disord. 2006. PMID: 17272944 Clinical Trial. - [Pharmacological therapy of obesity].
Pagotto U, Vanuzzo D, Vicennati V, Pasquali R. Pagotto U, et al. G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. G Ital Cardiol (Rome). 2008. PMID: 18773755 Italian. - Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM. Avenell A, et al. Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. doi: 10.3310/hta8210. Health Technol Assess. 2004. PMID: 15147610 Review. - Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.
Sari R, Balci MK, Cakir M, Altunbas H, Karayalcin U. Sari R, et al. Endocr Res. 2004 May;30(2):159-67. doi: 10.1081/erc-200027356. Endocr Res. 2004. PMID: 15473126 Clinical Trial.
Cited by
- Time-Restricted Eating for 12 Weeks Does Not Adversely Alter Bone Turnover in Overweight Adults.
Lobene AJ, Panda S, Mashek DG, Manoogian ENC, Hill Gallant KM, Chow LS. Lobene AJ, et al. Nutrients. 2021 Mar 31;13(4):1155. doi: 10.3390/nu13041155. Nutrients. 2021. PMID: 33807284 Free PMC article. Clinical Trial. - The metabolic consequences of 'yo-yo' dieting are markedly influenced by genetic diversity.
Thillainadesan S, Lambert A, Cooke KC, Stöckli J, Yau B, Masson SWC, Howell A, Potter M, Fuller OK, Jiang YL, Kebede MA, Morahan G, James DE, Madsen S, Hocking SL. Thillainadesan S, et al. Int J Obes (Lond). 2024 Aug;48(8):1170-1179. doi: 10.1038/s41366-024-01542-2. Epub 2024 Jul 3. Int J Obes (Lond). 2024. PMID: 38961153 Free PMC article. - Predictors of Preoperative Weight Loss in Morbidly Obese Adults Waiting for Bariatric Surgery: A Prospective Cohort Study.
Bergh I, Kvalem IL, Risstad H, Cameron LD, Sniehotta FF. Bergh I, et al. Obes Surg. 2015 Sep;25(9):1610-7. doi: 10.1007/s11695-015-1569-y. Obes Surg. 2015. PMID: 25616397 - Effects of 5 % weight loss through diet or diet plus exercise on cardiovascular parameters of obese: a randomized clinical trial.
Fayh AP, Lopes AL, da Silva AM, Reischak-Oliveira A, Friedman R. Fayh AP, et al. Eur J Nutr. 2013 Aug;52(5):1443-50. doi: 10.1007/s00394-012-0450-1. Epub 2012 Oct 7. Eur J Nutr. 2013. PMID: 23052625 Clinical Trial. - Interpreting weight losses from lifestyle modification trials: using categorical data.
Christian JG, Tsai AG, Bessesen DH. Christian JG, et al. Int J Obes (Lond). 2010 Jan;34(1):207-9. doi: 10.1038/ijo.2009.213. Epub 2009 Oct 13. Int J Obes (Lond). 2010. PMID: 19823184 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical